Dna X annual return on equity
2019
2020
2021
2022
2023
2024
Dna X Return on Equity (ROE) Growth & History (SONM)
Dna X's return on equity was −403.74% for fiscal 2024.
View full Dna X company overviewDna X annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −403.74% | −403.32 pp |
| 2023 | 2023-12-31 | −0.42% | +72.42 pp |
| 2022 | 2022-12-31 | −72.85% | +91.38 pp |
| 2021 | 2021-12-31 | −164.23% | −53.24 pp |
| 2020 | 2020-12-31 | −110.99% | +57.56 pp |
| 2019 | 2019-12-31 | −168.55% | — |
Dna X quarterly return on equity
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −448.00% | −442.05 pp |
| Q3 2024 | 2024-09-30 | −15.31% | −17.66 pp |
| Q2 2024 | 2024-06-30 | −35.46% | −37.87 pp |
| Q1 2024 | 2024-03-31 | −13.77% | −14.88 pp |
| Q4 2023 | 2023-12-31 | −5.95% | −0.83 pp |
| Q3 2023 | 2023-09-30 | 2.35% | +13.97 pp |
| Q2 2023 | 2023-06-30 | 2.40% | +49.26 pp |
| Q1 2023 | 2023-03-31 | 1.11% | +49.76 pp |
| Q4 2022 | 2022-12-31 | −5.12% | +69.84 pp |
| Q3 2022 | 2022-09-30 | −11.62% | +73.82 pp |
| Q2 2022 | 2022-06-30 | −46.86% | −5.58 pp |
| Q1 2022 | 2022-03-31 | −48.65% | −9.85 pp |
| Q4 2021 | 2021-12-31 | −74.96% | −54.54 pp |
| Q3 2021 | 2021-09-30 | −85.44% | −68.11 pp |
| Q2 2021 | 2021-06-30 | −41.28% | −16.05 pp |
| Q1 2021 | 2021-03-31 | −38.80% | +9.20 pp |
| Q4 2020 | 2020-12-31 | −20.42% | +7.91 pp |
| Q3 2020 | 2020-09-30 | −17.33% | +1.21 pp |
| Q2 2020 | 2020-06-30 | −25.23% | −0.11 pp |
| Q1 2020 | 2020-03-31 | −48.00% | +55.09 pp |
| Q4 2019 | 2019-12-31 | −28.34% | — |
| Q3 2019 | 2019-09-30 | −18.55% | — |
| Q2 2019 | 2019-06-30 | −25.12% | — |
| Q1 2019 | 2019-03-31 | −103.09% | — |
Dna X return on equity trends
Over the last five fiscal years, Dna X's return on equity decreased from −168.55% to −403.74%, a change of −235.19 percentage points. The latest reported quarter, Q4 2024, shows −448.00%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dna X source filings ↗